Newsfeeds - Spark Newswire

7 minute read

85 Biggest Movers From Yesterday

Today, 8:09 AM

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.

ABVC

2 minute read

Movers

Understanding Nautilus’s Unusual Options Activity

By Benzinga Insights

Today, 8:09 AM

Nautilus (NYSE:NLS) shares experienced unusual options activity on Tuesday. The stock price moved down to $13.02 following the option alert.

NLS

4 minute read

54 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 8:09 AM

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.

ACI

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 10, 2021

By Benzinga Insights

Today, 8:09 AM

ARCT

1 minute read

Roth Capital Maintains Neutral on Nautilus, Lowers Price Target to $12.5

By Benzinga Newsdesk

Today, 8:09 AM

Roth Capital analyst George Kelly maintains Nautilus (NYSE:NLS) with a Neutral and lowers the price target from $17 to $12.5.

NLS

2 minute read

12 Consumer Discretionary Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 8:09 AM

ATER

1 minute read

Craig-Hallum Downgrades Nautilus to Hold

By Benzinga Newsdesk

Today, 8:09 AM

Craig-Hallum analyst Steven Dyer downgrades Nautilus (NYSE:NLS) from Buy to Hold.

NLS

1 minute read

Nautilus Stock Falls After Q1 Results, Faces Margin Pressure

By Shivani Kumaresan

Today, 8:09 AM

Nautilus Inc (NYSE:NLS) reported first-quarter FY22 sales growth of 61.7% year-on-year, to $184.6 million, beating the analyst consensus of $169.05 million.…

NLS

1 minute read

Earnings

Recap: Nautilus Q1 Earnings

By Benzinga Insights

Today, 8:09 AM

Shares of Nautilus (NYSE:NLS) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 54.26% over the past year to $0.43, which beat the estimate of $0.30.

NLS

1 minute read

Nautilus Q1 Adj. EPS $0.43 Beats $0.30 Estimate, Sales $184.60M Beat $169.05M Estimate

By Benzinga Newsdesk

Today, 8:09 AM

Nautilus (NYSE:NLS) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.30 by 43.33 percent. This is a 54.26 percent decrease over earnings of $0.94 per share from the same

NLS